Re-Imagining Personalized Medicine through Artificial Intelligence: From Diagnosis to Drug Delivery

By enabling previously unheard-of personalization of medical treatments through advanced computer analysis of intricate biomedical data, Artificial Intelligence (AI) has emerged as a revolutionary force in precision medicine. The changing field of AI applications in precision medicine is examined in this study, which highlights both well-established technology and cutting-edge developments that are changing clinical practice. AI is transforming every aspect of patient care in the field of personalized medicine, from early diagnosis and risk assessment to the development of tailored treatment regimens and targeted drug delivery systems. Large-scale medical data, computational modelling, and state-of-the-art machine learning algorithms have come together to enable these developments. This study investigates how AI improves personalized illness management through the integration of technology from several domains, such as clinical decision support systems, genomic data analysis, medical imaging, and predictive analytics. AI's capacity to interpret genetic data and analyze medical imaging allows for both early and precise disease detection as well as patient-specific treatment plans. Additionally, by combining traditional and complementary therapies, AI-driven technologies promote integrative medicine, optimize therapy pathways, and modify medication regimens. AI improves the efficiency of healthcare workflows by streamlining administrative chores in addition to its clinical applications. The study's findings suggest that AI has significantly improved diagnostic accuracy, shortened the time needed to identify diseases, and increased the efficacy of individualized treatment regimens.